Method for illness and disease determination and management

• US 7,003,346 B2
• Filed: 11/04/2003
• Issued: 02/21/2006
• Est. Priority Date: 05/03/2001
• Status: Expired due to Term

• Current Assignee: The Nutrition Solutions Corporation
• Original Assignee: Michaeal G. Singer
• Inventors: Singer, Michaeal G.
• Primary Examiner(s): Hoang, Tu
• Application Number:
  US10/701,004
• Publication Number:
  US 20040092841A1
• Time in Patent Office: 840 Days
• Field of Search: 600/300, 600384-386, 600/506, 600546-547, 600/536, 600/587, 128/898, 439/586, 324/713, 324/600
• US Class Current: 600/547
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0537 Measuring body composition by impedance, e.g. tissue hydration or fat content
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: G01N 33/48707 by electrical means G01N33/49, G01N33/493 take precedence

Abstract

A method for detecting the presence and severity of illness, the effectiveness of treatment interventions, and the ability to change treatment to be more effective or aggressive, to optimize outcomes, to limit morbidity and mortality, and to illustrate a patient'"'"'s prognosis, including the steps of using whole body impedance analysis to measure a patient'"'"'s resistance, reactance, phase angle, and related electrical values at a healthy baseline, and thereafter in relation to the patient'"'"'s complaints, evaluating temporal or progressive nature of negative values or diminution of the measured values of resistance, reactance, phase angle, and related electrical values over time.

Claims

1. A method for detecting the presence and severity of illness, the effectiveness of treatment interventions, and the ability to change treatment to be more effective or aggressive, to optimize outcome, limit morbidity and mortality and illustrate the patient'"'"'s prognosis, comprising the steps of:

employing the use of whole body impedance analysis to measure a patient'"'"'s resistance, reactance, phase angle, and related electrical values at a healthy baseline; and

thereafter in relation to the patient'"'"'s complaints, evaluating temporal or progressive nature of negative values or diminution of said measured values of said patient'"'"'s resistance, reactance, phase angle, and related electrical values over time.

2. A method according to claim 1, including:

identifying the patient'"'"'s healthy baseline electrical values; and

during routine health examinations or when the patient complains of any symptoms or experiences any signs of illness or injury, illustrating excursion from said baseline values which exceed a thirty-day timeline or progressively diminish.

3. A method according to claim 1, wherein:

values of said phase angle less than four degrees denote serious illness of the patient; and

values of said phase angle less than two degrees denote imminent death of the patient.

4. A method according to claim 2, wherein:

values of said phase angle less than four degrees denote serious illness of the patient; and

values of said phase angle less than two degrees denote imminent death of the patient.

5. A method for detecting the presence and severity of illness, the effectiveness of treatment interventions, and the ability to change treatment to be more effective or aggressive, to optimize outcomes, to limit morbidity and mortality and illustrate the prognosis for a patient, comprising the steps of:

employing whole body impedance analysis to take a first measurement of resistance, reactance, phase angle, and related electrical values of a patient at a healthy baseline;

thereafter in relation to complaints of said patient, again employing whole body impedance analysis to take a second measurement of said resistance, reactance, phase angle and related electrical values of said patient; and

evaluating temporal or progressive nature of negative values of diminution of said measured values of resistance, reactance, phase angle, and related electrical values over time.

6. A method according to claim 5, including:

identifying the patient'"'"'s healthy baseline electrical values; and

during routine health examinations or when the patient complains of any symptoms or experiences any signs of illness or injury, illustrating excursion from said baseline values which exceed a thirty-day timeline or progressively diminish.

7. A method according to claim 5, wherein:

values of said phase angle less than four degrees denote serious illness of the patient; and

values of said phase angle less than two degrees denote imminent death of the patient.

8. A method according to claim 6, wherein:

values of said phase angle less than four degrees denote serious illness of the patient; and

values of said phase angle less than two degrees denote imminent death of the patient.

9. A method according to claim 5, including the steps of:

recording, archiving, and graphically presenting said measured values of resistance, reactance, phase angle and related electrical values to illustrate changes over time and to illuminate processes of disease progression and response to treatment.

10. A method according to claim 6, including the steps of:

recording, archiving, and graphically presenting said measured values of resistance, reactance, phase angle and related electrical values to illustrate changes over time and to illuminate processes of disease progression and response to treatment.

11. A method according to claim 7, including the steps of:

recording, archiving, and graphically presenting said measured values of resistance, reactance, phase angle and related electrical values to illustrate changes over time and to illuminate processes of disease progression and response to treatment.

12. A method according to claim 8, including the steps of:

recording, archiving, and graphically presenting said measured values of resistance, reactance, phase angle and related electrical values to illustrate changes over time and to illuminate processes of disease progression and response to treatment.

13. A method according to claim 5, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

14. A method according to claim 6, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

15. A method according to claim 7, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

16. A method according to claim 8, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

17. A method according to claim 9, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

18. A method according to claim 10, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

19. A method according to claim 11, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.

20. A method according to claim 12, wherein:

episodic illness and recoverable injury is characterized by a less than 30-day excursion below said baseline values and return to said baseline values.